TLTiancong Liu

Tiancong Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tiancong Liu has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Chen Zhu

    Department of Neurosurgery, The First Hospital of China Medical University

    3 shared publications
  • Siqi Wang

    Department of Radiation Oncology, The First Hospital of China Medical University, Shenyang, China

    3 shared publications
  • Zhongxue Yu

    Department of Cardiovascular Ultrasound, The First Hospital of China Medical University, Shenyang, China

    3 shared publications
  • Ziang Geng

    Department of Neurosurgery, The First Hospital of China Medical University, Shenyang, China

    3 shared publications
  • Jun Lu

    Department of Neurosurgery, The First Hospital of China Medical University, Shenyang, China

    2 shared publications
  • Shisong Wang

    Department of Neurosurgery, The First Hospital of China Medical University, Shenyang, China

    2 shared publications

Latest Publications

  • Open Access

    Targeting stromal cells in tumor microenvironment as a novel treatment strategy for glioma

    by Ziang Geng, Zheyuan Zhang, Miaohan Wang, Zhongxue Yu, Siqi Wang, Jun Lu, Shisong Wang, Shu Guan, Jinna Li, Tiancong Liu, et al.

    Glioma is the most common primary malignant tumor of the central nervous system in adults, characterized by high mortality, low cure rate and high recurrence rate. Among gliomas, glioblastoma multiforme (GBM) is the most malignant subtype. Currently, the standard treatment for patients with GBM is maximum surgical excision combined with radiotherapy and chemotherapy. But only a small percentage of patients benefit from this standard treatment. The tumor microenvironment plays an important role in the occurrence and development of most tumors. It is primarily composed of tumor cells, peripheral blood vessels, extracellular matrix, signaling molecules, stromal cells, and immune cells. The role of stromal cells in GBM has emerged as the focus of current research. The interaction among tumor, stromal, and immune cells within the tumor microenvironment can influence tumor development. Traditional research and drug therapy in glioma mainly focus on the tumor cells themselves, but recent studies have found that targeting stromal cells in the tumor microenvironment can also modulate tumor progression in GBM. Here, we review the influence of stromal cells in the tumor microenvironment of GBM on tumor cells and its related mechanism, as well as related molecular targets and signaling pathways, providing new ideas for the treatment and prognosis of GBM.


  • Open Access

    Neddylation of protein, a new strategy of protein post-translational modification for targeted treatment of central nervous system diseases

    by Qian Wu, Ziang Geng, Jun Lu, Shisong Wang, Zhongxue Yu, Siqi Wang, Xiaolin Ren, Shu Guan, Tiancong Liu, Chen Zhu

    Neddylation, a type of protein post-translational modification that links the ubiquitin-like protein NEDD8 to substrate proteins, can be involved in various significant cellular processes and generate multiple biological effects. Currently, the best-characterized substrates of neddylation are the Cullin protein family, which is the core subunit of the Cullin-RING E3 ubiquitin ligase complex and controls many important biological processes by promoting ubiquitination and subsequent degradation of various key regulatory proteins. The normal or abnormal process of protein neddylation in the central nervous system can lead to a series of occurrences of normal functions and the development of diseases, providing an attractive, reasonable, and effective targeted therapeutic strategy. Therefore, this study reviews the phenomenon of neddylation in the central nervous system and summarizes the corresponding substrates. Finally, we provide a detailed description of neddylation involved in CNS diseases and treatment methods that may be used to regulate neddylation for the treatment of related diseases.


  • Open Access

    Intercellular mitochondrial transfer in the brain, a new perspective for targeted treatment of central nervous system diseases

    by Ziang Geng, Shu Guan, Siqi Wang, Zhongxue Yu, Tiancong Liu, Shaonan Du, Chen Zhu

    Aim: Mitochondria is one of the important organelles involved in cell energy metabolism and regulation and also play a key regulatory role in abnormal cell processes such as cell stress, cell damage, and cell canceration. Recent studies have shown that mitochondria can be transferred between cells in different ways and participate in the occurrence and development of many central nervous system diseases. We aim to review the mechanism of mitochondrial transfer in the progress of central nervous system diseases and the possibility of targeted therapy.Methods: The PubMed databank, the China National Knowledge Infrastructure databank, and Wanfang Data were searched to identify the experiments of intracellular mitochondrial transferrin central nervous system. The focus is on the donors, receptors, transfer pathways, and targeted drugs of mitochondrial transfer.Results: In the central nervous system, neurons, glial cells, immune cells, and tumor cells can transfer mitochondria to each other. Meanwhile, there are many types of mitochondrial transfer, including tunneling nanotubes, extracellular vesicles, receptor cell endocytosis, gap junction channels, and intercellular contact. A variety of stress signals, such as the release of damaged mitochondria, mitochondrial DNA, or other mitochondrial products and the elevation of reactive oxygen species, can trigger the transfer of mitochondria from donor cells to recipient cells. Concurrently, a variety of molecular pathways and related inhibitors can affect mitochondrial intercellular transfer.Conclusion: This study reviews the phenomenon of intercellular mitochondrial transfer in the central nervous system and summarizes the corresponding transfer pathways. Finally, we propose targeted pathways and treatment methods that may be used to regulate mitochondrial transfer for the treatment of related diseases.